HEPION PHARMACEUTICALS INC (HEPA) Stock Balance Sheet
NASDAQ:HEPA - Nasdaq - US4268973025 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.50M | 14.79M | 51.20M | 91.30M | 40.70M | |||
| Receivables | 600.00K | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.43M | 2.70M | 5.30M | 6.10M | 1.90M | |||
| Total Current Assets | 3.53M | 17.49M | 56.50M | 97.50M | 42.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 118.30K | 242.37K | 100.00K | 500.00K | 700.00K | |||
| Goodwill | N/A | N/A | 0.00 | 1.90M | 1.90M | |||
| Intangibles | N/A | 0.00 | 3.20M | 3.20M | 3.20M | |||
| Other Non-Current Assets | 66.51K | 364.19K | 400.00K | 600.00K | 300.00K | |||
| Total Non-Current Assets | 184.81K | 606.56K | 3.70M | 6.10M | 6.00M | |||
| TOTAL ASSETS | 3.72M | 18.09M | 60.20M | 103.60M | 48.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 2.11M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 423.95K | 2.56M | 4.90M | 2.80M | 900.00K | |||
| Accounts Payable | 186.26K | 2.35M | 2.70M | 2.40M | 3.70M | |||
| Other Current Liabilities | 0.00 | 386.00K | 400.00K | 3.00M | 0.00 | |||
| Total Current Liabilities | 2.72M | 5.29M | 7.90M | 8.20M | 4.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 200.00K | |||
| Deferred Taxes/Income | N/A | 0.00 | 400.00K | 400.00K | 400.00K | |||
| Other Non-Current Liabilities | 1.41M | 5.52M | 2.10M | 1.90M | 2.90M | |||
| Total Non-Current Liabilities | 1.41M | 5.52M | 2.50M | 2.40M | 3.40M | |||
| TOTAL LIABILITIES | 4.12M | 10.81M | 10.40M | 10.60M | 8.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -236.27M | -224.63M | -175.70M | -133.50M | -104.10M | |||
| Additional Paid In Capital | 234.22M | 230.29M | 223.90M | 224.80M | 142.90M | |||
| Common Shares | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M | |||
| Other Shareholders' Equity | -53.83K | -78.78K | -100.00K | N/A | N/A | |||
| Shares Outstanding | 6.96M | 4.82M | 3.80M | 3.80M | 1.60M | |||
| Tangible Book Value per Share | -0.30 | 1.16 | 11.84 | 22.68 | 21.06 | |||
| Total Shareholders' Equity | -406.69K | 7.28M | 49.90M | 93.00M | 40.50M | |||
| TOTAL LIABILITIES AND EQUITY | 3.72M | 18.09M | 60.20M | 103.60M | 48.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Current Ratio | 1.30 | 3.31 | 7.15 | 11.89 | 9.06 | |||
| Return On Assets (ROA) | -611.14% | -270.39% | -75.32% | -31.58% | -41.89% | |||
| Return On Equity (ROE) | N/A | -671.99% | -90.86% | -35.18% | -50.27% | |||
All data in USD , ROIC based on taxRate of 0.21